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Introduction 
Traumatic brain injury (TBI) is a critical public health problem throughout the world (Roozenbeek et al., 2013) . It will become the third cause of death and disability in the general population by the year 2030 (Rai et al., 2017) . Early determination of injury severity is important in order to improve care, balance benefits and risks of early treatment options. Existing predictors include age, Glasgow Coma Scale (GCS), pupil response and grading of extent/type of TBI damage on imaging (Raj et al., 2014) . In recent years, researches have been devoted to find biomarkers that can improve the predictive capacity of demographic, clinical and imaging factors (Strathmann et al., 2014) . Kövesdi et al. (2010) ascertained that biomarkers to be specific and sensitive, it should be proportional to the mechanical impact and the extent of the injury, as well as, appear rapidly in the blood.
The most established approach to develop biomarkers for brain trauma is to identify proteins abundant in brain cells e.g.: neuronspecific enolase (NSE) and Ubiquitin Cterminal hydrolase-L1 (UCH-L1) in neurons; S100B and glial fibrillary acidic protein (GFAP) in astroglia. The second approach is to study inflammatory cytokines, oxidized lipids and metabolites (Bogoslovsky et al., 2016) .
The NSE is a glycolytic protein. It can be used as an indicator of functional levels and mortality rates after brain injury (Böhmer et al., 2011) . This protein is passively released into the extracellular space only under pathological conditions during cell destruction (Papa et al., 2015) and its concentration rises to its peak 6 hours after the injury (Woertgen et al., 2001) .
Visfatin is a newly identified proinflammatory adipokine which was found to be produced and secreted in visceral fat. Many researchers reported that it has a close relationship with inflammation and tissue damage repair (Xiao et al., 2015) . Circulating visfatin concentrations have been reported to be elevated in patients with type 2 diabetes mellitus, obesity, ischemic stroke and rheumatoid arthritis (Huang et al., 2013) .
Genetic polymorphism C > T located in the visfatin gene promoter has been suggested to be associated with the regulation of visfatin expression in some inflammatory illness (Chen et al., 2012) . Weng et al. (2013) found that the visfatin gene-mutation-induced various genotypes were greatly related with the conditions of patients with TBI.
The brain is highly sensitive to oxidative stress. Under physiological conditions, the defense system is able to prevent the formation or scavenge of these harmful molecules, protecting tissues from oxidative damage. In brain injury, there is a considerable increase in the production of free radicals (Arent et al., 2014) .
The main objective of this study was to evaluate the role of plasma visfatin and its gene mutation in patients with TBI, and its correlation to changes of other blood biomarkers e.g. neuron specific enolase (NSE), Malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione (GSH). Also, this study aimed to estimate the possible value of these markers for the prediction of TBI severity.
Patients and Methods

Patients, design and procedures:
The study group consisted of 78 brain trauma patients admitted to the Department of Neurosurgery, Assiut University Hospital. Upon admission at trauma emergency room, patients were evaluated. The excluded patients were described by Papa et al. 2015 as they were less than 18 years of age, admission time > 6h, existing previous head trauma, neurological disease including ischemic or hemorrhagic stroke, presence of prior systemic diseases as liver cirrhosis, diabetes mellitus, malignancy, chronic heart or lung disease, hypertension and obesity as well as use of anticoagulant medication.
The patients were divided according to Glasgow Coma Scale (GCS) criteria. GCS (13-15) was considered mild; GCS (9-12) was moderate while GCS (3-8) was considered severe injury (Di Battista et al., 2015) . Head CT scan was done for all patients. Demographic data (age, sex) was obtained. To highlight the results, 20 healthy people were enrolled as control group.
Blood sample collection and analysis:
Venous blood (10 ml) was drawn from patients on admission and from control group, into EDTA glass tubes. Eight milliliters were centrifuged at 1500 round per minute (rpm) for 20 min to collect plasma. Plasma was stored at -70 o C until analysis of different biochemical markers. The remaining 2 ml was stored at - Enzyme linked immunosorbent assay technique (ELISA) was performed to measure plasma concentrations of visfatin and NSE, using commercial kit (Cat No.30092, Ray Biotech, 3607, Parkway Lane Suite 200, Norcross) for visfatin and commercial kit (Cat no. 153308, MyBioSour , P.O. Box San Diego, California, United States) for NSE following the instructions supplied with the kits. Samples were measured as duplicate for single experiment.
(B) Measurement of oxidative markers:
Analysis
of lipid peroxides malondialdehyde derivative (MDA), as an index for oxidative stress, superoxide dismutase (SOD) and glutathione (GSH), as antioxidants, were done by spectrophotometry.
Malondialdehyde
derivative was determined by chemical method according to Ohkawa et al. (1979) which based on the oxidation of zylenol orange into purple colored chromogen that is proportional with the peroxide content in the presence of ferrous sulfate as a catalyzer. It was measured at 532 nm in spectrophotometer.
Superoxide dismutase activity was determined according to its ability to inhibit the auto-oxidation of epinephrine at alkaline media as described by Misra and Fridovich (1972) . Spectrum was measured at 480nm.
Glutathione was assayed according to method of Jollow et al. (1974) which relies on mixing 1 mL of sample with 1.0 mL of sulfosalicylic acid (4%). The samples were incubated at 4ºC for at least 1h, and then centrifuged at 1200 rpm for 15 min at 4ºC.The reaction mixture contained 0.4mL of filtered sample, 2.2 mL phosphate buffer (0.1M , pH 7.4), and 0.4 mL dithionitrobenzoic acid (DTNB) in a total volume of 3 mL. The yellow color developed was read immediately at 412 nm by spectrophotometer.
(C) DNA extraction and genotyping:
Genomic DNA extraction was done using the Patho Gene-spin TM DNA/RNA Extraction Kit (iNtRON Biotechnology. Made in Korea). Lot. No. 11650150. Cat. No.17154 according to manufacturer's guidelines and stored at -80°C until genotyping.
Visfatin gene polymorphisms were studied by PCR followed by RFLP as described by Wang et al. (2011) . The primer used was 5′TGTTTCAAACCTCGTTGCTGA-3′ and reverse 5′AGTGATGGTGGTGGTGGTA-3′. PCR products were digested and visualized in 3% agarose gel electrophoresis. The genotypes of visfatin were characterized as TT (283bp), TC (283bp, 218 bp), and CC (218bp) as reported by Xiao et al. (2015) .
Statistical Analysis
Statistical analysis was performed with SPSS 20.0 (SPSS Inc. Chicago, USA).
The categorical variables are presented as percentages, and the continuous variables are presented as mean ± standard deviation. Comparisons were made using Chi-square test or Fisher exact test for categorical data and unpaired Student t-test and Mann-Whitney for continuous variables. When p < 0.05, the difference was statistically significant. The correlation, of visfatin and its gene with other markers, was assessed by Spearman's correlation coefficient.
Ethical considerations
The study was reviewed and approved by Research and Ethical committee of Faculty of Medicine, Assiut University (no:17300207). Written informed consent was taken from control group and relatives of TBI who participated in the study. Confidentiality of the data was guaranteed.
Results
Patient characteristics:
Seventy eight patients, admitted to Neurosurgery Department with an isolated head trauma, were included in the study. Twenty healthy people were included as control group. Patients were 50 males and 28 females with mean age of (52.38± 1.65) years. The control group was 13 males and 7 females with mean age of (53.86±2.7y). There were no significant differences in both sex and age among patients and control subjects (both p > 0.05). These characteristics were listed in the table (1). Regarding GCS criteria, they were 52 moderate TBI patients and 26 severely injured. The causes of TBI and CT scan results of patients were shown in table (2). Motor car accident (MCA) represented the major cause of trauma in 20 cases (25.6%), followed by motor bike accident (MBA) in 16 cases (20.5%), while Fall on ground (FOG) and Fall on stairs (FOS) were the cause in 4 injuries (5.1%) for each. Regarding CT scan results, sixteen patients (20.5%) showed brain edema, and eight cases (10.3%) showed contusion. Extradural hemorrhage represented the highest type of intracranial hemorrhage among included patients, in 20 cases. Depressed fracture was found in 6 cases (7.7%).
Biochemical markers:
Visfatin concentration was significantly elevated (p < 0.001) in severe TBI patients as compared to moderate TBI patients (28 ± 1.68 µg/L, 25± 2.09 µg/L) respectively. Its concentration was highly significantly elevated (p < 0.0001) in both TBI groups as compared to control (7.62± 0.87 µg/L). Also, NSE concentration was significantly higher (p < 0.0001) in severe TBI patients as compared to moderate TBI patients (20.47±3 ng/ml, 13.49 ± 2.66 ng/ml) respectively. Its concentration was highly significantly elevated (p < 0.0001) in both TBI groups as compared to control(4.3 ± 0.52 ng/ml) as shown in table (3) (2).
The correlation of plasma visfatin concentration in TBI patients and other biochemical parameters was illustrated in table (5). Visfatin was positively correlated with NSE (r = 0.699, p < 0.01) and MDA (r = 0.338, p < 0.05). While there was negative correlation with SOD (r = -0.156, non-significant) and GSH (r = -0.588, p < 0.01).
Visfatin genotyping:
Visfatin gene C > T locus had three genotypes: TT was characterized at 283bp, TC at 283bp, 218 bp and CC at 218bp (Figure 3 Figure 4 ). MDA: Malondialdehyde, SOD: Superoxide dismutase, GSH: Glutathione, SD: Standard deviation, n: number, ns nonsignificant, * :significant difference as compared to moderately injured patients, #: significant difference as compared to control Fig. (2) : Effects of traumatic brain injury on MDA, SOD and GSH in studied groups (moderate injured patients, severe injured patients and control). MDA: Malondialdehyde, SOD: Superoxide dismutase, GSH: Glutathione. 
Discussion
Head trauma is one of common injury related mortality and morbidity. Traumatic brain injury patients represent the greatest challenge for accurate diagnosis and outcome prediction especially in the acute setting "within 24 h after injury" (Undén et al., 2015) .
Prognosis can be assessed by many predictors such as age, neurological examination of some clinical variables e.g. Glasgow Coma Scale (GCS), loss of consciousness (LOC) and posttraumatic amnesia (PTA). In addition, neuroimaging tools such as MRI and CT scanning can be used (Schaan et al., 2002 and Balestreri et al., 2004) .
In brain trauma, blood biomarkers are preferable than CSF for accurate and rapid assessments, as they are cost effective; and require minimally invasive sample collection, compared to CSF collected by invasive method as lumbar puncture (LP) or ventriculostomy (Katawa et al., 2016) .
Circulating serological biochemical markers may be associated with secondary injury progression and poor prognosis. A single factor has insufficient predictive value to distinguish patients who will do poorly from those who will be good (Mushkudiani et al., 2008) . Thus, for accuracy, a multi-marker approach to characterize traumatic brain injured patients outcome has been advocated and may increase diagnostic and prognostic accuracy and may prove multi-systemic character of secondary injury pathology (Di Battista et al., 2015) .
This research aimed to diagnose traumatic brain injury by assessing five blood biomarkers, each associated with a specific traumatic brain related injury process : Visfatin as pro-inflammatory adipokine, as well as Genetic polymorphism C > T located in the visfatin gene promoter for regulation of visfatin expression; neuron specific enolase (NSE) relating to neuronal injury; lipid peroxides malondialdehyde derivative (MDA) for oxidative stress; superoxide dismutase (SOD) and glutathione (GSH), as antioxidants. Also, to correlate the change in plasma visfatin to other biomarkers, as well as, to clinical severity after traumatic brain injury, for which, no published information exists to date about this.
Seventy eight patients were included in the study. Males were more than females (as most TBI cases were due to outdoor activities). Regarding GCS criteria, they were 52 moderate TBI patients and 26 severely injured .No mild cases were evaluated, as Assiut University Hospital (AUH) is a big referral hospital for all Upper Egypt governorates. The emergency units in AUH are tertiary level units receiving all types of trauma, either direct or referred from other hospitals. Therefore, they admit patients to undergo operative treatment or admitted to the intensive care in trauma unit (Abdel-Hameed et al., 2017) .
Visfatin has a vital role in the pathogenesis of vascular inflammation and it was closely related with inflammation and repair after tissue damage (Wang et al., 2011) . Thrombin and fibrin degradation products can induce a series of inflammatory reactions after traumatic brain injury, so the generation and the concentration of most inflammatory factors increase (Lozano et al., 2015) .
In the presented study, visfatin concentration was significantly elevated in severe TBI patients as compared to moderate TBI patients .Its concentration was highly significantly elevated in both TBI groups as compared to control.
This was consistence with Chen et al. (2012) , who reported for the first time significantly higher visfatin levels in patients with severe TBI. In addition, Weng et al. (2013) demonstrated highest plasma visfatin and C-reactive protein concentrations among head injured patients.
The NSE is a marker present in the neuron cell body (Selakovic et al., 2005) . Ogata and Tsuganezawa (1999) ascertained that NSE is a surrogate marker of neuronal damage. They found elevated NSE with injured axons in the corpus callosum of patients sustaining fatal diffuse axonal injury, while, NSE is nearly undetectable in patients with non-injured axons or control subjects.
The results of this study showed that NSE concentration was also, significantly higher in severe TBI patients as compared to moderate TBI patients. Its concentration was highly significantly elevated in both TBI groups as compared to control.
In agreement with the presented study, Lee et al. (2017) reported that NSE could be used as an indicator of functional levels and mortality rates after head injury. Vos et al. (2004) found elevated NSE levels, correlated with the injury severity score and CT findings and were significantly higher in in patients with poor outcome post injury. McKeating et al. (1998) found that NSE in serum peaks within 6 h after injury and decreases during the subsequent hours. Multiple studies have shown that serum NSE levels spike after moderate to severe head injury (Skogseid et al., 1992; de Kruijk et al., 2001; Anand and Stead, 2005; Guzel et al., 2008; Meric et al., 2010 and Cheng et al., 2014) .
In addition, Di Battista et al. (2015) found unfavorable neurological outcome was associated with elevations in six of the seven markers including neuron specific enolase (NSE), and lipid peroxidation.
In controversy with that, Shahim et al. (2014) reported no difference in serum NSE in post-concussion values among 35 concussed ice hockey players. This may be explained as in concussion there is no actual damage or injury to brain cells, hence there is no elevation of its level.
One of the major factors that can cause tissue damage initiated by head trauma is lipid peroxidation (Demir et al., 2013) . There are intracellular lactate production and hyperglycaemia, during the acute ischemic phase of brain injury, which leads to subsequent development of reactive oxygen species (Li et al., 1999 and Diaz Parejo et al., 2003) .
In this study, MDA, as an indicator of lipid peroxidation, was significantly elevated in severe TBI patients as compared to moderate TBI patients. While, this elevation was nonsignificant in moderate TBI patients, it was significantly elevated in severe TBI patients when compared to control. Regarding superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, SOD concentration was significantly decreased in severe TBI patients as compared to moderate TBI patients .Glutathione, was highly significant decreased in severe TBI patients as compared to moderate TBI patients. Both, SOD and GSH, were highly significantly decreased when compared to control.
Similarly, Kasprzak et al. (2001) demonstrated that increased erythrocyte TBARS concentrations were correlated with the severity of injury in the patients with brain contusion. This elevation in lipid peroxidation was associated with unfavorable neurological outcome (Di Battista et al., 2015) . Rodriguez et al. (2004) stated that when the tissues are exposed to oxidative stress, they increase the expression of antioxidant enzymes as a compensatory mechanism against free radical-mediated damage. And they ascertained that the increased activity of the antioxidant enzymes may be inadequate to counteract the potential damage in many conditions of oxidative stress. So, the decreased levels of antioxidants in the presented study lead to highly elevated oxidative stress conditions. This consistent with Ozdemir et al. (2005) who found that whereas TBI significantly increased thiobarbituric acid reactive substances (TBARS) levels, there was no compensatory increase in SOD and glutathione peroxidase (GPx) 24 hours after TBI in 7-day-old rats. In addition, the depleted level of glutathione in the tissues may lead to progressing oxidative stress and more complications (Arent et al., 2014 and Rai et al., 2017) .
Regarding visfatin gene, in the presented study, its C > T locus had three genotypes: TT was characterized at 283bp, TC at 283bp, 218 bp and CC at 218 bp. Patients with severe TBI were mostly CC genotype , while moderate TBI patients were TC and TT genotype carriers This genotype seemed to have a role in determination of plasma visfatin level (Weng et al., 2003) . In addition, Xiao et al. (2015) indicated that higher visfatin levels and CC genotype were associated with traumatic brain injury among Chinese population. As well as Ye et al. (2005) showed that visfatin was reduced in patients with the T variant.
Whereas, Tokunaga et al. (2008) suggested that this variation might be not functional among Japanese.
Differences in experimental conditions, ethnicity and geographic variation may account for this discrepancy.
The genotype CC had the highest plasma visfatin, enolase, MDA concentrations and lowest SOD and GSH. While this concentration between the variant genotypes CT and TT did not differ significantly in the presented results.
Studies have shown that clinical practice guidelines have an impact on the outcomes of trauma cases (Hyams et al., 1995) . Hence, it is of great importance to incorporate new modalities of diagnosis and prognosis in forensic evaluation of medical care (Shahin et al., 2016) .
Conclusion
Traumatic brain injury can release number of injury related molecules which are easily assessed in the peripheral blood. These biomarkers could facilitate diagnosis and may hold promise in the clinical management of patients. This research studied the predictive performance of some circulating biomarkers which reflect specific pathological mechanisms including neuro inflammation, neuron injury and oxidative damage in moderate to severe traumatic brain injury patients. Expression of visfatin and its CC gene mutation in patients with traumatic brain injury were closely related to the severity of TBI.
Recommendations
Studying the prognostic utility of the change in blood levels of these biomarkers in mild injured patients, for longer-term outcome and in large enough sample size. 
